BeStock  
Stocks › Biotechnology › EPRX

Eupraxia Pharmaceuticals EPRX

US equityMarket cap rank #3682Biotechnology
$5.80 −$0.32 (-5.23%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $5.80 0.00%
Open$6.11
Prev close$6.12
Day range$5.69 – $6.42
Volume361.7K
Market cap$390.16M
P/E (TTM)–
Dividend yield–

EPRX Stock News

Headlines matching Eupraxia Pharmaceuticals or the EPRX ticker, most recent first.

  • Stifel Maintains Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating, Maintains Target Price $25Market news · 24 Sep 2026 · Direct mention
  • Wedbush Initiates Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating, Announces Target Price $17Market news · 24 Sep 2026 · Direct mention
  • H.C. Wainwright Keeps Their Buy Rating on Eupraxia Pharmaceuticals (EPRX)TipRanks · 22 Sep 2026 · Direct mention
  • H.C. Wainwright Maintains Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating, Maintains Target Price $11Market news · 22 Sep 2026 · Direct mention
  • William Blair Maintains Eupraxia Pharmaceuticals(EPRX.US) With Buy RatingMarket news · 27 Aug 2026 · Direct mention
  • LifeSci Capital Maintains Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating, Maintains Target Price $16Market news · 27 Aug 2026 · Direct mention
  • A Quick Look at Today's Ratings for Eupraxia Pharmaceuticals(EPRX.US), With a Forecast Between $11 to $25Market news · 13 Aug 2026 · Direct mention
  • Cantor Fitzgerald Maintains Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating, Maintains Target Price $19Market news · 20 Jul 2026 · Direct mention
  • Oppenheimer Initiates Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating, Announces Target Price $17Market news · 26 Jun 2026 · Direct mention
  • Oppenheimer Maintains Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating, Maintains Target Price $17Market news · 26 Jun 2026 · Direct mention
  • Craig-Hallum Maintains Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating, Announces Target Price $14Market news · 5 May 2026 · Direct mention
  • H.C. Wainwright Remains a Buy on Eupraxia Pharmaceuticals (EPRX)TipRanks · 4 May 2026 · Direct mention
  • Stifel Initiates Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating, Announces Target Price $25Market news · 21 May 2026 · Direct mention
  • William Blair Initiates Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating, Announces Target Price $14Market news · 23 Mar 2026 · Direct mention
  • H.C. Wainwright Maintains Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating, Cuts Target Price to $11 NegativeMarket news · 17 Mar 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on EPRX.

Sign in to join the discussion.

Scroll to Top